F. A. Luzzio, O. E. Okoromoba / Tetrahedron Letters 52 (2011) 6530–6533
6533
discharge. Upon complete consumption of starting material, the THF is
removed by rotary evaporation and the oily residue is dissolved in
minimum of dichloromethane. The CH2Cl2 solution of the crude product is
then directly applied to a silica gel flash column and eluted with hexane/ethyl
acetate (4:1). The pure fractions were then combined and concentrated under
vacuum to afford the pure 1,3-dihydro-isobenzofurans 2a–h.
minor), 7.96 (d, 2H, J = 8.5 Hz, major), 7.58 (t, 2H, J = 7.5 Hz), 7.48 (m, 4H), 7.30
(m, 6H), 7.17 (d, 1H, J = 7.5 Hz, minor), 7.08 (d, 1H, J = 7.0 Hz, major), 5.96 (dt,
1H, J = 3.6 Hz, major), 5.93 (d, 1H, J = 2.5, major), 5.86 (t, 1H, J = 6.5 Hz, minor),
5.72 (s, 1H, minor), 3.58 (dd, 1H, J = 7, 12.5 Hz, minor), 3.56 (dd, 1H, J = 5.5,
16.5, major), 3.30 (dd, 1H, J = 6.0, 11, minor), 3.29 (dd, 1H, J-6, 17 Hz, major),
2.62 (m, 1H, minor), 2.55 (m, 1H, minor), 2.49 (m, 1H, major), 2.30 (m, 1H,
major), 2.13 (m, 2H, minor/major), 1.98 (m, 1H, minor), 1.82 (m, 1H, major),
1.71 (m, 8H, minor/major); 13C NMR (100 MHZ, CDCl3) d: 197.64, 197.49,
142.71, 142.41, 136.93, 136.89, 136.86, 136.81, 133.40, 133.37, 128.96, 128.86,
128.65 (overlap), 128.64 (overlap), 128.33 (overlap), 128.26, 128.20 (overlap),
128.16, 122.23, 122.17, 121.93, 121.78, 102.62, 102.16, 86.29, 85.26, 80.39,
79.64, 46.12, 46.03, 35.16, 35.02, 33.63, 31.90, 24.62, 24.58, 24.49, 24.26;
a
10. (a) Barfield, M.; Spear, R. J.; Sternhell, S. J. Am. Chem. Soc. 1971, 93, 5322–5327;
(b) Petracek, F. J.; Sugisaka, N.; Klohs, M. W.; Parker, R. G.; Bordner, J.; Roberts,
J. D. Tetrahedron Lett. 1970, 10, 707–710.
11. Ethyl 2-(3-(2-nitropropan-2-yl)-1,3-dihydroisobenzofuran-1-yl) acetate. (2a,
Table 1): (oil, 1.5:1 diastereomeric mixture) Rf 0.44 (hexane/EtOAc, 2:1);
FTIR 2986, 1730, 1536, 1348, 1159, 1042 cmꢀ1 1H NMR (500 MHz, CDCl3) d:
;
7.35 (m, 2H), 7.30 (m, 2H), 7.21 (m, 2H), 5.77 (s, 1H, major), 5.71(m, 1H, minor),
5.70 (s, 1H, major), 5.62 (m, 1H, minor), 4.21 (q, 2H), 4.19 (q, 2H), 2.81 (dd, 1H),
2.68 (m, 3H), 1.24 (t, 1H, major), 1.3 (t, 1H, minor), 1.46 (s, 3H, major), 1.52 (s,
3H, minor), 1.58 (s, 3H, major), 1.62 (s, 3H, minor); 13C NMR (125 MHz, CDCl3)
d: 170.59 (overlap), 142.24, 142.10, 136.78, 136.62, 129.25, 129.20, 128.67,
128.61, 122.64, 122.51, 121.75, 121.73, 91.47, 90.45, 87.36, 87.16, 81.02, 80.15,
61.08, 60.92, 42.25, 42.17, 23.57, 22.84, 21.44, 20.98, 14.44, 14.37; HRMS calcd
for C15H20NO5 (M+H)+ 294.1341; found 294.1349. 1-(3-(2-Nitropropan-2-yl)-
1,3-dihydroisobenzofuran-1-yl)propan-2-one (2b, Table 1): (oil, 2:1
diastereomeric mixture) Rf 0.38 (hexane/EtOAc, 2:1); FTIR 2997, 1712, 1534,
HRMS calcd for C
21H21NaNO4 374.1362 (M+Na)+, Found 374.1363. 3,3-
Dimethyl-1-(3-(2-nitropropan-2-yl)-1,3-dihydroiso benzofuran-1-yl) butan-2-
one. (2 g, Table 1): (oil, 1.7:1 diastereomeric mixture) Rf 0.56 (hexane/EtOAc,
2:1); FTIR 1702, 1536, 1460, 1369, 1348, 1041 cmꢀ1 1H NMR (CDCl3) d: 7.28
;
(m, 4H), 7.26 (m, 2H), 7.06 (m, 2H), 5.78 (dt, 1H, J = 2.8, 5.6 Hz, major), 5.74 (d,
1H, J = 2.8 Hz, major), 5.70 (t, 1H, J = 5.6 Hz, minor), 5.62 (s, 1H, minor), 3.11
(dd, 1H, J = 7.2, 17.2 Hz, minor), 3.08 (dd, 1H, J = 6, 17.2 Hz, major), 2.77 (dd,
1H, J = 5.6, 17.2 Hz, minor), 2.72 (dd, 1H, J = 6.4, 16.8 Hz, major), 3.28 (s, 3H,
minor), 1.55 (s, 6H, overlap, minor, major), 1.43 (s, 3H, major); 13C NMR
(100 MHz, CDCl3) d: 213.37, 212.92, 143.02, 142.68, 136.52, 136.35, 129.31,
128.98, 128.85, 128.16 (overlap), 122.29, 122.11, 121.77, 121.60, 91.35, 90.21,
86.83 (overlap), 80.84 (overlap), 79.57, 44.31, 43.86, 26.07 (overlap), 23.12,
1396, 1348, 1049 cmꢀ1 1H NMR (400 MHz, CDCl3) d: 7.31 (m, 4H), 7.18 (t, 2H),
;
7.09 (t, 2H), 5.75 (s, 1H, major), 5.73 (m, 1H, major), 5.65 (s, 1H, minor), 5.62
(m, 1H, minor), 2.9 (dd, 2H), 2.77 (dd, 2H), 2.26 (s, 3H, minor), 2.20 (s, 3H,
major), 1.61 (s, 3H, minor), 1.56 (s, 6H, minor, major, overlap), 1.45 (s, 3H,
major); 13C NMR (100 MHz, CDCl3) d: 206.25, 206.11, 142.40, 142.19, 136.23
(overlap), 129.07, 128.97, 128.31, 128.28, 122.37, 122.19, 121.61, 121.53,
91.31, 90.25, 87.12, 87.06, 80.46, 79.53, 50.67 (overlap), 30.93 (overlap), 22.89,
22.29, 21.76, 20.88; HRMS calcd for C14H17NNaO4 (M+Na)+ 286.1055; Found
286.1049. 1-(3-(3-Methyl-1-nitrobutyl)-1,3-dihydroisobenzo furan-1-yl)propan-
2-one. (2c, Table 1): (oil, 1:1:1:1 diastereomeric mixture) Rf 0.42 (hexane/
22.50, 21.75, 20.69; HRMS calcd for
C
17H24NO4 306.1705 (M+H)+, Found
306.1697. 1-(7-(2-Nitropropan-2-yl)-5,7-dihydroisobenzo furo[5,6-d][1,3]dioxol-
5-yl)propan-2-one. (2h, Table 1): (oil, 2:1 diastereomeric mixture) Rf 0.30
(hexane/EtOAc, 2:1); FTIR 2996, 2898, 1708, 1536, 1476, 1347, 1259,
1034 cmꢀ1 1H NMR (400 MHz, CDCl3) d: 6.58 (d, 2H, J = Hz), 6.47 (d, 2H,
;
J = 8 Hz), 5.97 (s, 4H), 5.61 (m, 1H, major), 5.58 (m, 1H, major), 5.51 (s, 1H,
minor), 5.49 (m, 1H, minor), 2.86 (dd, 1H, J = 6.8, 16.8 Hz, major), 2.85 (dd, 1H,
J = 7.2, 16.4 Hz minor), 2.76 (dd, 1H, J = 5.2, 16.4 Hz, minor), 2.70 (dd, 1H,
J = 5.2, 16.8 Hz, major), 2.23 (s, 3H, minor), 2.17 (s, 3H, major), 1.59 (s, 3H,
minor), 1.54 (s, 3H, major), 1.53 (s, 3H, minor), 1.42 (s, 3H, major); 13C NMR
(100 MHz, CDCl3) d: 206.39, 206.21, 148.91, 148.87, 148.40, 148.36, 135.72,
135.53, 128.90 (overlap), 102.70, 102.54, 102.05 (overlap), 101.92 (overlap),
91.37, 90.31, 87.16, 87.04, 80.39, 79.49, 50.91, 50.87, 30.98, 30.96, 22.98, 22.50,
21.67, 20.69; HRMS calcd for C15H17LiNO6 (M+Li)+ 314.1216, Found 314.1208.
12. (a) Fustero, S.; Moscardo, J.; Sanchez-Rosello, M.; Rodriguez, F.; Barrio, P. Org.
Lett. 2010, 12, 5494–5497; (b) Suwa, T.; Nishino, K.; Miyatake, M.; Shibata, I.;
Baba, A. Tetrahedron Lett. 2000, 41, 3403–3406; (c) Suwa, T.; Shibata, I.;
Nishino, K.; Baba, A. Org. Lett. 1999, 1, 1579–1581; (d) Dai, W.-M.; Lee, M. Y. H.
Tetrahedron Lett. 1998, 39, 8149–8152; (e) Shigematsu, N.; Hayashi, K.;
Kayakiri, N.; Takase, S.; Hashimoto, M.; Tanaka, H. J. Org. Chem. 1993, 58,
170–175.
EtOAc, 2:1); FTIR 1960, 2874, 1713, 1545, 1460, 1371 cmꢀ1 1H NMR (400 MHz,
;
CDCl3) d: 7.32 (m, 2H), 7.18 (m, 1H), 7.10 (m, 1H), 5.73 (m, 2H), 5.66 (t, 2H,
J = 6 Hz), 5.56 (m, 1H), 5.50 (m, 2H), 5.43 (d, 1H, J = 5.6), 4.76 (m, 3H), 4.63 (m,
1H), 2.90 (m, 8H), 2.27 (s, 3H), 2.26 (s, 3H), 2.24 (m, 4H), 2.21 (s, 6H), 1.61 (m,
8H), 0.94 (m, 24H); 13C NMR (100 MHz, CDCl3) d: 218.66, 218.45, 218.20,
218.02, 142.23 (overlap), 141.52 (overlap), 136.95 (overlap), 136.58 (overlap),
129.18 (overlap), 129.11, 128.47, 128.40, 128.08 (overlap), 122.56, 122.31,
121.87, 121.79 (overlap), 121.70 (overlap), 121.63 (overlap), 90.46, 90.04,
89.79, 89.55, 83.91, 83.70, 83.61 (overlap), 80.16, 79.99, 79.93, 79.50, 51.15,
51.02, 50.32, 50.17, 38.31, 38.08, 37.78, 37.71, 31.28, 31.03, 30.94, 30.80, 25.05
(overlap), 24.97, 23.19, 23.08. 21.33, 21.12 (overlap), 21.04 (overlap), 20.89,
20.82; HRMS calcd for C16H22NO4 (M+H)+ 292.1549, Found 292.1543. HRMS
calcd for
C
16H22NO4 (M+H)+ 292.1549, Found 292.1543. 1-(3-(1-
Nitrocyclopentyl)-1, 3-dihydroisobenzofuran-1-yl) propane-2-one. (2d, Table 1):
(oil, 1.3:1 diastereomeric mixture) Rf 0.4 (hexane/EtOAc, 2:1); FTIR 2962, 2878,
13. The a,b-unsaturated-b-(ortho-formyl)phenyl substrates such as those listed in
Table 1 have recently been synthesized and used as key intermediates in the
stereoselective synthesis of 1,3-disubstituted isoindolines; see Ref. 12a.
14. Banfi, L.; Basso, A.; Casuscelli, F.; Guanti, G.; Naz, F.; Riva, R.; Zito, P. Synlett
2010, 85–88.
15. Ono, N.; Miyake, H.; Tamura, R.; Kaji, A. Tetrahedron 1981, 22, 1705–1708.
16. 1-(3-Isopentyl-1,3-dihydroisobenzofuran-1-yl)propan-2-one. 3: To a solution of
1-(3-(3-Methyl-1-nitrobutyl)-1,3-dihydroiso-benzofuran-1-yl) propan-2-one
2c (62.5 mg, 0.21 mmol) in dry toluene (3.0 mL) was added tri-n-butyltin
1713, 1532, 1359, 1160, 1049 cmꢀ1 1H NMR (400 MHz, CDCl3) d:7.3 (m, 2H),
;
7.27 (m, 2H), 7.15 (m, 3H), 7.05 (d, 1H, J = 7.2 Hz), 5.87 (d, 1H, J=2.4 Hz, major),
5.70 (m, 1H, major), 5.68 (s, 1H, minor), 5.59 (s, 1H, minor), 2.88 (dd, 2H, J = 7.2,
16.4 Hz, overlap), 2.76 (dd, 2H, J = 4.8, 16 Hz, overlap), 2.55 (m, 3H), 2.3 (m,
1H), 2.56 (s, 3H, minor), 2.19 (s, 3H, major), 2.04 (m, 3H), 1.82 (m, 1H), 1.72 (m,
8H); 13C NMR (100 MHz, CDCl3) d: 206.39, 206.25, 142.31, 142.09, 136.64,
136.62, 128.97, 128.86, 128.24, 128.17, 122.25, 122.19, 121.54, 121.45, 102.56,
102.18, 86.41, 85.37, 80.13, 79.42, 50.79, 50.64, 34.82, 34.68, 33.74, 32.14,
31.06, 30.89, 24.63, 24.53, 24.41, 24.29; HRMS calcd for C16H19NaNO4 (M+Na)+
312.1212, Found 312.1206. 2-(3-(2-Nitropropan-2-yl)-1,3-dihydroisobenzo
furan-1-yl)-1-phenylethanone. (2e, Table 1): (oil, 4:1 diastereo-meric mixture)
hydride (93.6
(10.5 mg, 0.064 mmol). The mixture was then refluxed under nitrogen (3 h, oil
bath) and another portion of n-butyltin hydride (93.6 l) and AIBN (10.5 mg)
lL, 0.32 mmol) by syringe followed by azobisisobutyronitrile
l
was added. Stirring was continued (2 h) where upon TLC analysis (hexane/
EtOAc, 10:1) indicated full consumption of 2c and the more mobile product.
Toluene was then removed under rotary evaporation and the oily yellow
residue was then flash-chromatographed on silica gel (hexane/EtOAc, 10:1) to
afford 3 (35 mg, 68%) as a 50/50 mixture of diastereomers (colorless oil): Rf
0.19 (hexane/EtOAc, 10:1); FTIR 2955, 2931, 2869, 1714, 1460, 1365,
Rf 0.5 (hexane /EtOAc, 2:1); FTIR 2922, 1678, 1541, 1447, 1212, 1053 cmꢀ1 1H
;
NMR (400 MHz, CDCl3) d: 8.0 (d, 2H, J = 6 Hz), 7.95 (d, 2H, J = 6 Hz), 7.57 (m,
2H), 7.48 (m, 4H), 7.30 (m, 6H), 7.09 (d, 2H, J = 6 Hz), 5.98 (m, 1H, major), 5.86
(m, 1H, minor), 5.79 (s, 1H, major), 5.67 (s, 1H, minor), 3.59 (dd, 1H, overlap,
minor), 3.57 (dd, 1H, J = 4.8, 13.6 Hz, major), 3.35 (dd, 1H, 4.8, 13.6 Hz, minor),
3.28 (dd, 1H, J = 5.2, 13.6 Hz, major), 1.63 (s, 3H, minor), 1.58 (s, 3H, major),
1.56 (s, 3H, minor), 1.47 (s, 3H, major); 13C NMR (100 MHz, CDCl3) d: 197.49,
197.38, 142.82, 142.56, 136.87, 136.38, 133.48, 133.41, 129.08 (overlap),
128.96 (overlap), 128.73 (overlap), 128.66 (overlap), 128.30 (overlap), 128.27
(overlap), 128.22 (overlap), 122.34, 122,19, 122.03, 121.90, 91.39, 90.29, 87.04,
86.98, 80.72, 79.69, 46.18, 45.95, 23.33, 22.59, 21.65, 20.75; HRMS calcd for
1161 cmꢀ1 1H NMR (500 MHz, CDCl3) d: 7.28 (m, 4H), 7.16 (m, 4H), 5.68 (m,
;
1H), 5.59 (t, 1H, J = 6.5), 5.26 (m, 1H), 5.18 (t, 1H, J = 5 Hz), 2.91 (dd, 1H, J = 7.5,
17 Hz), 2.89 (d, 2H, J = 5.5), 2.80 (dd, 1H, J = 5,16 Hz), 2.72 (s, 3H), 2.23 (s, 3H),
1.91 (m, 1H), 1.83 (m, 1H), 1.69 (m, 2H), 1.57 (m, 2H), 1.34 (m, 4H); 13C NMR
(125 MHz, CDCl3) d: 206.94, 206.91, 142.35, 142.24, 141.57, 141.47, 127.32,
127.70, 127.52 (overlap), 121.24, 121.19, 121.14, 121.10, 83.47, 83.27, 78.88,
78.83, 51.29, 50.62, 34.44, 34.29, 34.19, 33.93, 31.11, 30.95, 28.11, 28.03, 22.62,
22.58, 22.46, 22.45; HRMS calcd for C16H22NaO2 (M+Na)+ 269.1512, Found
269.1513.
C
19H20NO4 326.1392 (M+H)+, Found: 326.1405. 2-(3-(1-Nitrocyclopentyl)-1,3-
dihydroisobenzofuran-1-yl)-1-phenylethan one. (2f, Table 1): (oil, 4:1
diastereomeric mixture) Rf 0.52 (hexane/EtOAc, 2:1); FTIR 2961, 2876, 1681,
1531, 1448, 1209 cmꢀ1 1H NMR (500 MHz, CDCl3) d: 8.02 (d, 2H, J = 8.5 Hz,
;